CGS 12970: a novel, long acting thromboxane synthetase inhibitor
Article first published online: 19 JUL 2012
1985 British Pharmacological Society
British Journal of Pharmacology
Volume 86, Issue 2, pages 497–504, October 1985
How to Cite
Ambler, J., Butler, K. D., Ku, E. C., Maguire, E. D., Smith, J. R. and Wallis, R. B. (1985), CGS 12970: a novel, long acting thromboxane synthetase inhibitor. British Journal of Pharmacology, 86: 497–504. doi: 10.1111/j.1476-5381.1985.tb08920.x
- Issue published online: 19 JUL 2012
- Article first published online: 19 JUL 2012
- Received May 3, 1985. Accepted July 8, 1985
- 1CGS 12970 is a potent selective inhibitor of human platelet thromboxane synthestase in vitro (IC50 = 12 nM). It is four orders of magnitude less potent as an inhibitor of sheep seminal vesicle cyclo-oxygenase, bovine aorta prostacyclin synthetase and human leucocyte 15-lipoxygenase.
- 2The compound inhibited collagen-induced thromboxane B2 production by human platelets in vitro without an effect on the accompanying platelet aggregation induced by collagen, ADP, platelet activating factor, thrombin, arachidonic acid or the prostaglandin mimetic, U 46619.
- 3Administration of CGS 12970 to rats inhibited collagen-induced thromboxane B2 production but had no effect on platelet aggregation ex vivo. It also had no effect on platelet aggregation induced by thrombin or on plasma clotting times.
- 4A single oral dose of 1 or 3 mg kg−1 to rabbits inhibited thromboxane B2 production in clotting blood ex vivo for 12 or 24 h respectively.
- 5CGS 12970 inhibited thromboxane B2 production in vivo induced by intravenous administration of collagen to rats or calcium ionophore to guinea-pigs. In both cases there was a concomitant elevation of immunoreactive 6-keto-prostaglandin F1α but no effect on the induced thrombocytopenia.
- 6As with other thromboxane synthetase inhibitors, CGS 12970 prolonged tail bleeding time in the rat. However, CGS 12970 was not as potent as other thromboxane synthetase inhibitors in this test.
- 7In addition to these usual effects of thromboxane synthetase inhibitors, CGS 12970 inhibited the thrombocytopenia induced by the Forssman reaction or ADP administration. In these tests the effect of the compound was of short duration.
- 8CGS 12970 had no effect on the thrombocytopenia associated with the Arthus reaction which distinguishes it from cyclo-oxygenase inhibitors. It also had no effect on thrombus formation on a cotton thread in an arteriovenous shunt in the rat.